e-ESO Podcasts

143 Folgen

1. Angiosarcoma Essentials

   Vom: 18.12.2024
2. The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients

   Vom: 12.12.2024
3. Women’s Health Frontiers: Breakthroughs from ESMO 2024

   Vom: 28.11.2024
4. ESMO Congress Prostate Cancer Highlights

   Vom: 14.11.2024
5. How to interpret prognostic models papers in hematology and oncology

   Vom: 31.10.2024
6. Stage III Lung Cancer Resecability

   Vom: 17.10.2024
7. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

   Vom: 3.10.2024
8. Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)

   Vom: 19.9.2024
9. Fear of recurrence: one of the major elements in reactivating cancer

   Vom: 25.7.2024
10. Immunohistochemistry in oncology

    Vom: 11.7.2024
11. Thrombosis and cachexia in cancer: Two partners in crime?

    Vom: 13.6.2024
12. From clinical and academic culture in radiation oncology - how to cross the chasm?

    Vom: 30.5.2024
13. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    Vom: 16.5.2024
14. Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

    Vom: 30.4.2024
15. Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

    Vom: 18.4.2024
16. The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

    Vom: 4.4.2024
17. Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

    Vom: 20.3.2024
18. An inter-specialty cancer training programme curriculum for Europe

    Vom: 7.3.2024
19. Communicating the oncological diagnosis: a psycho-oncological perspective

    Vom: 22.2.2024
20. ESMO 2023 Highlights on lung cancer

    Vom: 8.2.2024